Post-earnings recap
Reported
Tue, May 5, 2026
EPS actual
$2.70
EPS est.
$2.31
EPS surprise
+17.09%
1-day move
+13.54%
Waters Corporation reported a strong earnings per share, significantly exceeding expectations, which likely contributed to the stock's 13.54% increase. However, revenue figures were not disclosed, leaving some uncertainty about overall performance. Investors may view the EPS beat as a positive sign for the company's profitability.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.70 | $2.31 | +17.09% |
| Revenue | — | $1.2B | — |
No transcript is on record, and the analysis is based solely on numerical results.
Waters Corporation (WAT) operates in the health care sector, focusing on life sciences tools and services. The company is known for its advanced analytical instruments and software that help scientists and researchers in drug development and quality control, making it a crucial player in the life sciences industry.
Last quarter
In Q4-2025, Waters Corporation reported an EPS of $4.53, slightly beating estimates but saw a significant stock drop of nearly 14% the following day. This reflects potential investor concerns despite the earnings beat.
EPS beat streak
8Q
EPS beat rate
100%
Avg EPS surprise
+4.85%
Avg 1-day reaction
+2.67%
Analysts expect Waters Corporation to report solid earnings this quarter, with a consensus EPS of $2.31 and revenue of $1.2 billion. The market is cautiously optimistic, given the company's strong historical performance.
Bull case
If Waters can exceed EPS expectations and show strong revenue growth, it may signal robust demand for its products, leading to a positive stock reaction.
Bear case
Conversely, if the company fails to meet EPS estimates or provides weak guidance, it could raise concerns about future growth, resulting in a negative market reaction.
Key metrics to watch
EPS
$2.31Earnings per share is a key indicator of profitability and will show how well the company is managing its costs and generating income.
Revenue
$1.2BRevenue figures provide insight into the company's sales performance and market demand for its products and services.
The print will turn on these.
Q1
Will the EPS exceed $2.31, and by how much?
A significant EPS beat could indicate strong operational efficiency and demand, positively impacting investor sentiment.
Q2
What guidance does management provide for future revenue growth?
Future revenue guidance will be critical in assessing the company's growth trajectory and market position.
—
Est. EPS
$0.01
Est. Rev
$918M
Impl. Move
±9.1%
Why consensus could be wrong
The consensus may underestimate the potential for Waters to exceed its EPS target due to strong demand in the life sciences sector, which could drive better-than-expected results.
Supporting evidence
Waters has consistently beaten EPS estimates in the past, indicating strong operational performance.
The options market is pricing a significant move, suggesting that traders anticipate volatility and potential surprises.
Key risk
If the company reports an EPS below $2.27, it could challenge the current positive sentiment.
Pre-commit to what would confirm each case.
This quarter's performance will be closely watched as it will indicate the company's ability to sustain growth amid market challenges.
Bull confirmed if
An EPS of $2.35 or higher with revenue growth exceeding $1.2 billion would confirm the bull case.
Bear confirmed if
An EPS below $2.27 or revenue significantly underperforming expectations would confirm the bear case.
What the market is pricing for the move.
Implied Move
±7.10%
Historical Avg
±8.7%
The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings report.
Options are pricing ±7.4% while WAT has averaged ±8.7% over the last 8 prints — setup is roughly in line with history.
ATM IV
0.6%
30d HV
38.5%
Cross-company pattern from 30 similar setups.
Prior-quarter beat + options rich in Health Care
Fade rate: 0 of 30 (0%)
This setup has occurred 30 times across Health Care in the last 2 years. The average absolute 1-day move is 4.6%, with a raw directional average of +0.8% (modestly positive historical bias).
Smart-money positioning from the most recent 13F filings.
Institutional
102.08%
of float
Insider
0.10%
of float
Holders
1,614
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
8,484,939 sh · $3.7B
8.64%
-0.7%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Waters beats expectations, history suggests the stock could rise by around 0.84%, confirming strong operational performance.
In line / cautious
If results are in line with expectations, the stock may react cautiously, reflecting uncertainty in future growth.
Miss
A miss could lead to a decline, with history suggesting a potential drop of around 0.84% or more, raising concerns about the company's outlook.
House and Senate STOCK Act disclosures over the trailing 6 months.
Trades
1
0 buys·1 sell
Members
1
House only
Est. Notional
$1,001.00–$15,000.00
disclosed dollar ranges
Most Active Members
1 trade
The lines on the call that would change the story.
Vanguard Capital Management LLC
6,415,552 sh · $2.8B
6.53%
0.6%
Vanguard Portfolio Management LLC
4,740,524 sh · $2.1B
4.83%
-0.3%
Massachusetts Financial Services Co.
4,625,035 sh · $2.0B
4.71%
-0.1%
State Street Corporation
4,382,008 sh · $1.9B
4.46%
0.5%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.
Net selling
Recent Transactions
Traded Aug 13, 2026 · disclosed Sep 1, 2026
$1,001.00–$15,000.00
Filed 30–45+ days after the trade. Treat as positional context, not a leading indicator. Amounts are SEC-mandated dollar ranges, not exact values.